Head-to-head · Value Score
CoreAge Rx vs Oria Meds
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Oria Meds a 69. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameOria Meds
#255 · Grade C · Watch List
Est. first month
$199/mo month-to-month (four-week supply; the $149 on its homepage matches no plan in the signup)
Save ~85% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 69 — an est. $99/mo first month, with no teaser step-up baked in. Oria Meds isn't out of it: Readers willing to hand over a name, an email and a shipping address before learning which drug is being sold and what it costs.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Oria Meds |
|---|---|---|
| Value Score | 93 (A+) | 69 (C) |
| Est. first month | $99/mo | $199/mo month-to-month (four-week supply; the $149 on its homepage matches no plan in the signup) |
| Save vs brand-name | ~89% | ~85% |
| Semaglutide | $99/mo | $199/mo month-to-month (four-week supply; the $149 on its homepage matches no plan in the signup) |
| Tirzepatide | $149/mo | $369/mo month-to-month (four-week supply; three and six months cost $316 and $299 a month) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states claimed, no list published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Oria Meds
Compounded semaglutide at $199 a month and tirzepatide at $369, advertised as $149 and $249 — two figures that appear nowhere in the signup — on a public site that never names either molecule.
Why it's a deal
- The full ladder appears in the signup before payment, with each plan's dose schedule and supply length attached: a four-week supply at $199 or $369, and twelve- and twenty-four-week gradual-start plans beside them
- The dispensing pharmacy is named with a street address, a phone number, an email address and a website — a level of naming several better-priced desks in this batch do not match
- The provider network is named on the about page, in the privacy policy and in the subpage footers, so the clinical side is attributable to something
- Cancellation is through the patient portal or by email, stops all future charges, and is described as month-to-month with no long-term contract
- A mailing address is published on every page, and the plans state how often medication ships rather than leaving it to be discovered
The fine print
- The two prices on the homepage are not sold. "Starting at $149" and "starting at $249" appear nowhere in the signup, which was walked in two different states and returned the same ladder both times
- The semaglutide ladder is inverted: one month is $199 and both the three- and six-month plans work out to $209 a month, so committing longer costs more
- Neither molecule is named anywhere on the public site. Semaglutide and tirzepatide first appear at the second step of the signup, after a name, an email address, a phone number and a shipping address have been collected
- A second price table lives in the homepage code and renders nowhere, carrying different figures again for the same programs
- No legal entity, no state of organization and no governing law is published anywhere on the site — the only address is a suite widely used for registered-agent filings
- No clinician is named and no identifier is published for the provider network
- The pharmacy class appears only inside an unrendered script; a reader is told only that a licensed compounding pharmacy is used
- Two different scarcity counters run on consecutive screens, and the promised review turnaround is twenty-four hours on one screen and forty-eight on the next
- "Cancel anytime" sits beside terms saying medication is not refundable once dispensed, including partially used or unopened vials
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Oria Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.